Back to top

BARDA injects $30 million into Basilea’s phase 3 antifungal program

Basilea Pharmaceutica ( ($CH:BSLN) ) just unveiled an announcement. The U.S. Biomedical Advanced Research and Development Authority has released an...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Basilea Pharmaceutica AG (BPMUF)